KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Net Income (2016 - 2025)

Historic Net Income for Eli Lilly (LLY) over the last 16 years, with Q3 2025 value amounting to $5.6 billion.

  • Eli Lilly's Net Income rose 47533.75% to $5.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $18.4 billion, marking a year-over-year increase of 11997.99%. This contributed to the annual value of $10.6 billion for FY2024, which is 10208.38% up from last year.
  • Per Eli Lilly's latest filing, its Net Income stood at $5.6 billion for Q3 2025, which was up 47533.75% from $5.7 billion recorded in Q2 2025.
  • Eli Lilly's Net Income's 5-year high stood at $5.7 billion during Q2 2025, with a 5-year trough of -$57.4 million in Q3 2023.
  • Over the past 5 years, Eli Lilly's median Net Income value was $1.8 billion (recorded in 2023), while the average stood at $2.2 billion.
  • Per our database at Business Quant, Eli Lilly's Net Income crashed by 10395.4% in 2023 and then skyrocketed by 179041.81% in 2024.
  • Quarter analysis of 5 years shows Eli Lilly's Net Income stood at $1.7 billion in 2021, then increased by 12.26% to $1.9 billion in 2022, then grew by 13.01% to $2.2 billion in 2023, then surged by 101.39% to $4.4 billion in 2024, then rose by 26.59% to $5.6 billion in 2025.
  • Its Net Income was $5.6 billion in Q3 2025, compared to $5.7 billion in Q2 2025 and $2.8 billion in Q1 2025.